Mesoblast
MESO
28 hedge funds and large institutions have $16M invested in Mesoblast in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 7 closing their positions.
0.35% less ownership
Funds ownership: 2.06% → 1.71% (-0.35%)
7% less funds holding
Funds holding: 30 → 28 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
29% less capital inflows, than outflows
Capital inflows: $9.8M | Capital outflows: $13.8M
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
95% less call options, than puts
Call options by funds: $9K | Put options by funds: $165K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Penbrook Management
New York
|
+$56.1K |
| 2 |
Kore Private Wealth
New York
|
+$12.7K |
| 3 |
Wilbanks Smith & Thomas Asset Management
Norfolk,
Virginia
|
+$9.08K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.18K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$548 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Prudential plc
London, England,
United Kingdom
|
-$10.4M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$2.58M |
| 3 |
Old Mission Capital
Chicago,
Illinois
|
-$205K |
| 4 |
Jane Street
New York
|
-$172K |
| 5 |
JP Morgan Chase
New York
|
-$128K |
MESO Hedge Fund Activity: Q4 2019 in Review
28 of the 5,094 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q4 2019, worth a combined $16M — down 14% from $18.6M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of MESO and 5 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 5 added.
The largest buyer was Penbrook Management, adding an estimated $56.1K. The largest seller was Prudential plc, exiting entirely with an estimated $10.4M sold.
- 28 institutional investors held Mesoblast (MESO) as of Q4 2019, down from 30 in Q3 2019.
- Funds reported $16M of Mesoblast stock for Q4 2019, down 14% quarter-over-quarter.
- 5 funds opened new Mesoblast positions in Q4 2019 and 7 closed out, a net change of -2 holders.
- The largest Mesoblast buyer in Q4 2019 was Penbrook Management, an estimated $56.1K added.
- The largest Mesoblast seller in Q4 2019 was Prudential plc, an estimated $10.4M sold.
Based on aggregated 13F filings for Q4 2019.